Davy James, Managing Editor

Nearly 2 million cancer deaths have been avoided over last 25 years.

Study finds many silver plans have higher out-of-pocket costs for most the commonly prescribed HIV treatments.

CMS report shows spending rates are lower compared with the years prior to health care reform.

Top articles of the week on Specialty Pharmacy Times.

Nearly 2 million cancer deaths have been avoided over last 25 years.

Vitamin D3 found to aid immune response regulation among patients with MS.

Study finds adoption of Medicaid expansion could reduce disparities in breast cancer screening.

Study finds adoption of Medicaid expansion could reduce disparities in breast cancer screening.

David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, discusses methods to improve communication among drug manufacturers and health care providers.

Targeted intervention programs could offer significant benefits in HCV prevention.

Alpha therapy shows promise in selectively killing infected cells from the central nervous system.

Research may lead to new treatment approach for cancer.

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC discusses the use of technology to optimize clinical services in specialty pharmacy.

Combination of treatments may slow disease progression.

Most read HCV articles of the year.

Most read HIV articles from the past year.

Most read multiple sclerosis articles from the past year.

Catch up with the most popular articles from the print journal of Specialty Pharmacy Times this year.

Taking drug around periods of sexual activity lowers transmission rates.

Catch up with the most popular articles from the last year.

Keytruda acts by allowing T cells to recognize and attack cancer cells.

Early trial shows potential of stem cell transplant combined and high-dose chemotherapy.

Catch up with any news you may have missed this month.

Researchers explore alternate treatment for chronic lymphocytic leukemia.

Significant improvement in sustained disease remission following transplantation not observed.

Top stories of the week on Specialty Pharmacy Times.

Global AML market forecast to reach nearly a billion dollars by 2024.

Ibrutinib is significantly more effective than chlorambucil in chronic lymphocytic leukemia.

Joseph Morse, president and chief operating officer of Therigy, LLC, discusses how specialty pharmacies can meet the reporting requirements required by manufacturers and payers.

Experimental tyrosine kinase inhibitor targets T790M mutation-positive non-small cell lung cancer.